These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 770362)

  • 1. The movement pattern of oral tardive dyskinesia in relation to anticholinergic and antidopaminergic treatment.
    Gerlach J; Thorsen K
    Int Pharmacopsychiatry; 1976; 11(1):1-7. PubMed ID: 770362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between parkinsonism and tardive dyskinesia.
    Gerlach J
    Am J Psychiatry; 1977 Jul; 134(7):781-4. PubMed ID: 869056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia.
    Gerlach J; Reisby N; Randrup A
    Psychopharmacologia; 1974 Jan; 34(1):21-35. PubMed ID: 4593518
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between tardive dyskinesia, L-Dopa-induced hyperkinesia and parkinsonism.
    Gerlach J
    Psychopharmacology (Berl); 1977 Mar; 51(3):259-63. PubMed ID: 403541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial.
    Gerlach J; Thorsen K; Munkvad I
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):51-6. PubMed ID: 788002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cholinergic and anticholinergic agents on tardive dyskinesia.
    Klawans HL; Rubovits R
    J Neurol Neurosurg Psychiatry; 1974 Aug; 37(8):941-7. PubMed ID: 4418481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of baclofen on tardive dyskinesia.
    Gerlach J; Rye T; Kristjansen P
    Psychopharmacology (Berl); 1978 Mar; 56(2):145-51. PubMed ID: 417365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha methylparatyrosine and tetrabenazine in movement disorders.
    Lang AE; Marsden CD
    Clin Neuropharmacol; 1982 Dec; 5(4):375-87. PubMed ID: 6130839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.
    Simpson GM; Beckles D; Isalski Z; Lee JH
    J Clin Pharmacol New Drugs; 1972 Apr; 12(4):142-52. PubMed ID: 4553448
    [No Abstract]   [Full Text] [Related]  

  • 11. Baclofen (Lioresal) in the treatment ofneuroleptic-induced tardive dyskinesia.
    Korsgaard S
    Acta Psychiatr Scand; 1976 Jul; 54(1):17-24. PubMed ID: 782159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amantadine versus biperiden: a double-blind study of treatment efficacy in neuroleptic extrapyramidal movement disorders.
    König P; Chwatal K; Havelec L; Riedl F; Schubert H; Schultes H
    Neuropsychobiology; 1996; 33(2):80-4. PubMed ID: 8927233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):95-9. PubMed ID: 4555831
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical observations of the treatment of tardive dyskinesia with haloperidol.
    Frangos E; Christodoulides H
    Acta Psychiatr Belg; 1975 Jan; 75(1):19-32. PubMed ID: 785948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the differential diagnosis of hyperkinetic, dystonic side effects of psychopharmaca].
    Bellabarba U; Hippius H; Kanowski S
    Med Welt; 1967 Mar; 10():559-63. PubMed ID: 5587137
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology of tardive dyskinesia. Part II.
    Jus A; Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Villeneuve R
    Dis Nerv Syst; 1976 May; 37(5):257-61. PubMed ID: 1261344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [L-dopa, biperiden and sebum excretion in Parkinson disease].
    Villares JC
    Arq Neuropsiquiatr; 1989 Mar; 47(1):31-8. PubMed ID: 2764750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol-induced tardive dyskinesia in monkeys.
    Gunne LM; Bárány S
    Psychopharmacology (Berl); 1976 Nov; 50(3):237-40. PubMed ID: 826968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate in tardive dyskinesia.
    Fann WE; Davis JM; Wilson IC
    Am J Psychiatry; 1973 Aug; 130(8):922-4. PubMed ID: 4577471
    [No Abstract]   [Full Text] [Related]  

  • 20. The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy.
    Turunen S; Achté KA
    Psychiatr Q; 1967; 41(2):268-79. PubMed ID: 4383787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.